Point72 Asset Management
MLTX icon

Point72 Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Point72 Asset Management’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.5M Buy
1,368,518
+596,018
+77% +$9.87M 0.03% 681
2025
Q4 		$10.2M Buy
772,500
+762,700
+7,783% +$9M 0.01% 1347
2025
Q3 		$70.3K Sell
9,800
-176,768
-95% -$9.21M ﹤0.01% 2222
2025
Q2 		$8.81M Buy
+186,568
New +$7.6M 0.02% 781
2025
Q1 		– Sell
-98,719
Closed -$5.35M – 2345
2024
Q4 		$5.35M Buy
+98,719
New +$5.04M 0.01% 926
2023
Q2 		– Sell
-29,748
Closed -$636K – 2538
2023
Q1 		$636K Buy
+29,748
New +$500K ﹤0.01% 1186
2022
Q4 		– Sell
-335,000
Closed -$2.6M – 1689
2022
Q3 		$2.6M Buy
+335,000
New +$2.37M 0.01% 868
2021
Q1 		– Sell
-70,000
Closed -$796K – 1094
2020
Q4 		$796K Buy
+70,000
New +$743K ﹤0.01% 825

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return